Correlation Between PsyBio Therapeutics and Tryp Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Tryp Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Tryp Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PsyBio Therapeutics Corp and Tryp Therapeutics, you can compare the effects of market volatilities on PsyBio Therapeutics and Tryp Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Tryp Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Tryp Therapeutics.

Diversification Opportunities for PsyBio Therapeutics and Tryp Therapeutics

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between PsyBio and Tryp is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Tryp Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tryp Therapeutics and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Tryp Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tryp Therapeutics has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Tryp Therapeutics go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Tryp Therapeutics

If you would invest  5.00  in Tryp Therapeutics on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Tryp Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

PsyBio Therapeutics Corp  vs.  Tryp Therapeutics

 Performance 
       Timeline  
PsyBio Therapeutics Corp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Tryp Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

PsyBio Therapeutics and Tryp Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PsyBio Therapeutics and Tryp Therapeutics

The main advantage of trading using opposite PsyBio Therapeutics and Tryp Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Tryp Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tryp Therapeutics will offset losses from the drop in Tryp Therapeutics' long position.
The idea behind PsyBio Therapeutics Corp and Tryp Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments